Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Symcat
AddedFeb 18, 2024
UpdatedJun 18, 2026
Symcat

Symcat

Symcat: Leveraging medical data for symptom checking and personalized healthcare planning.

HQ
Baltimore, MD, US
Founded
2011
Overview
Compare
Fundraising
Employees

Symcat's core mission is to leverage medical data for symptom checking and personalized healthcare planning. The company offers a platform where users can input their symptoms to receive potential diagnoses and guidance on necessary medical care. Symcat focuses on improving healthcare accessibility and accuracy for individuals seeking medical advice.

Symcat has made significant strides in the digital health sector by providing a reliable and user-friendly symptom checker. Its impact is evident in the enhanced ability of users to make informed healthcare decisions. Notable achievements include widespread user adoption and positive feedback from the medical community.

Symcat - Similar Companies

Symptom.ly logo

Symptom.ly

Symptify logo

Symptify

MedDefend logo

MedDefend

mymeddefend.com

Symmpl logo

Symmpl

Buoy Health logo

Buoy Health

buoyhealth.com

Meddik logo

Meddik

Empericus logo

Empericus

Catalia Health logo

Catalia Health

Sympto Health logo

Sympto Health

relyhealth.com

Symvato logo

Symvato

Sniffle Health logo

Sniffle Health

sniffle.com

Sync logo

Sync

syncmd.com

ChartSynergy logo

ChartSynergy

MediSearch logo

MediSearch

medisearch.io

GetDoctor logo

GetDoctor

getdoctor.co

Symcat - Quick Facts

Who are Symcat's competitors?

Companies similar to Symcat include Symptom.ly, Symptify, MedDefend and Symmpl.

When was Symcat founded?

Symcat was founded in 2011.

Where is Symcat's headquarters located?

Symcat's headquarters is located in Baltimore, MD, US.

When was Symcat's last funding round?

Symcat's most recent funding round was for $134.7k (USD) in July 2012.

How much has Symcat raised to-date?

As of Jul 6, 2012, Symcat has raised a total of $154.7k (USD).

How many employees does Symcat have?

Symcat has 30 employees as of Feb 4, 2024.

Symcat - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • SaaS
Customer
  • Consumers
Main Product
  • Healthcare
  • Symptom Checker
Tags
  • AI Operations
  • Healthtech
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software